Loading...

Daxor Corporation

DXRNASDAQ
Healthcare
Medical - Instruments & Supplies
$10.14
$0.14(1.40%)

Daxor Corporation (DXR) Stock Overview

Explore Daxor Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 68.7/100

Key Financials

Market Cap50.8M
P/E Ratio94.10
EPS (TTM)$-0.09
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Week$9.09
1 Month$8.95
3 Months$8.39
1 Year Target$6.85

DXR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Daxor Corporation (DXR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.85.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 94.10 and a market capitalization of 50.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;